Table 1.
Clinical Characteristic of Patients at Enrollment
| Variable | 2019(n=161) | 2020(n=386) | 2021(n=318) | P |
|---|---|---|---|---|
| Age (years) | ||||
| <30 | 77(47.8%) | 167(43.3%) | 126(39.6%) | 0.152 |
| 30–50 | 71(44.1%) | 172(44.6%) | 164(51.6%) | |
| >50 | 13(8.1%) | 47(12.1%) | 28(8.8%) | |
| Sex | ||||
| Male | 156(96.9%) | 368(95.3%) | 306(96.2%) | 0.668 |
| Female | 5(3.1%) | 18(4.7%) | 12(3.8%) | |
| HIV transmission route | ||||
| Homosexual | 140(87.0%) | 270(69.9%) | 271(85.2%) | <0.01 |
| Heterosexual | 9(5.6%) | 44(11.4%) | 29(9.1%) | |
| Intravenous drug users | 0(0%) | 1(0.3%) | 0(0%) | |
| Former plasma donors | 1(0.6%) | 3(0.8%) | 0(0%) | |
| Unkown | 11(6.8%) | 68(17.6%) | 18(5.7%) | |
| CD4 cell count at baseline(cells/ul) | ||||
| <50 | 11(6.8%) | 90(23.4%) | 50(15.7%) | <0.01 |
| 50–199 | 20(12.4%) | 75(19.4%) | 65(20.4%) | |
| 200–349 | 52(32.3%) | 102(26.4%) | 97(30.5%) | |
| ≥350 | 77(47.8%) | 105(27.2%) | 89(28.0%) | |
| Unkown | 1(0.7%) | 14(3.6%) | 17(5.4%) | |
| CD4 count (cells/uL, IQR) | 349(317–380) | 275(240–285) | 253(221–285) | <0.01 |
| HIV-1 RNA at baseline (copies/mL) | ||||
| ≤100,000 | 115(71.4%) | 228(59.1%) | 201(63.2%) | 0.002 |
| >100,000 | 46(28.6%) | 145(37.6%) | 98(30.8%) | |
| Unkown | 0(0%) | 13(3.3%) | 19(6.0%) |